Código QR (código de barras bidimensional)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention

BackgroundIn patients with non‐ST‐segment elevation acute coronary syndromes, inhibition of platelet aggregation (IPA) with a potent P2Y12 inhibitor, ticagrelor, was inferior to tirofiban infusion at 2 hours, indicating that glycoprotein IIb/IIIa inhibitors are still needed. Ticagrelor and eptifibat...

Fuld beskrivelse

Na minha lista:
Principais autores: Moazez J. Marian, Oluseun Alli, Firas Al Solaiman, Brigitta C. Brott, Mark Sasse, Tara Leesar, Sumanth D. Prabhu, Massoud A. Leesar
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2017-11-01
Serier:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Fag:
antiplatelet therapy
eptifibatide
inhibition of platelet aggregation
ticagrelor
Online adgang:https://www.ahajournals.org/doi/10.1161/JAHA.117.005562
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker